Cullen Trims KVUE Stake With $149.5M Share Sale

Cullen Capital Management, LLC significantly reduced its position in Kenvue (KVUE) during Q2 2025, divesting 6,565,339 shares valued at approximately $149.46 million. This transaction decreased Kenvue's representation to 0.6% of the fund's assets under management, moving it out of their top five holdings. The move occurs as KVUE shares have underperformed significantly, falling 29.4% over the past year and lagging the S&P 500 by over 42 percentage points, prompting questions about the consumer defensive stock's future performance despite its 5.07% dividend yield.

Analysis

Cullen Capital Management executed a significant reduction in its Kenvue (KVUE) position during Q2 2025, selling 6.6 million shares valued at approximately $149.5 million. This divestment is a material change in the fund's conviction, reducing its KVUE holding to just 0.6% of assets under management and removing it from its top holdings. The sale occurred against a backdrop of severe underperformance by Kenvue stock, which declined 29.4% over the past year and lagged the S&P 500 by over 42 percentage points. This institutional selling pressure, combined with the negative price momentum, signals a bearish outlook. However, this contrasts sharply with the company's underlying fundamentals. Kenvue remains highly profitable, generating $1.42 billion in net income on a trailing-twelve-month basis, and offers a substantial 5.07% dividend yield. This creates a critical divergence for investors: the market is pricing in significant risk, while the company's current financial metrics suggest value and income potential. The key question is whether the stock's weakness reflects a temporary market dislocation or a more persistent challenge to Kenvue's long-term growth and margin profile that could threaten its earnings and dividend.

Key Decisions for Investors

• Income-oriented investors may find Kenvue's 5.07% dividend yield attractive after its 29.4% price decline, but must scrutinize the sustainability of the payout and the drivers of its significant market underperformance before committing capital.
• Given the substantial institutional selling by Cullen Capital and the stock's severe lag versus the S&P 500, existing holders should monitor upcoming earnings reports for evidence of business stabilization to justify maintaining their position.
• Investors should watch for subsequent 13F filings to determine if this large sale is an isolated portfolio rebalancing or the start of a broader institutional exit, which would signal increased downside risk for the stock.